Allergy and Asthma Center of NC, PA

High Point, North Carolina NC 27262

0 studies enrolling now · 3 studies all time

What they study most

Asthma, PAR, Perennial Allergic Rhinitis

Studies at this site

• A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR) — Completed
• A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR). — Completed
• Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation. — Completed